Literature DB >> 11260530

Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil.

R Minotto1, C D Bernardi, L F Mallmann, M I Edelweiss, M L Scroferneker.   

Abstract

BACKGROUND: If not diagnosed earlier, chromoblastomycosis has a chronic evolutional course that may cause several problems, such as difficulty in managing therapy because of the recrudescent character of the disease, potential association with the growth of epidermoid carcinoma in affected regions, and poor quality of life and work incapacity to the patient. Although infrequent, new cases are reported in the state of Rio Grande do Sul every year, ratifying the necessity for further studies on this disease.
OBJECTIVE: The purpose of this study was to review clinical features and response to therapy in patients with chromoblastomycosis and present data on the demography and history of this disease in the state of Rio Grande do Sul, Brazil.
METHODS: We reviewed case records of 100 patients with skin lesions caused by chromoblastomycosis, who were treated between 1963 and 1998. The cases were confirmed by the histopathologic and mycologic analyses made by the Dermatology Service of the Universidade Federal do Rio Grande do Sul at the Santa Casa de Misericórdia Hospital.
RESULTS: There was a predominance of male patients (4:1) and of white farmers whose ages ranged from 50 to 59 years, with lesions on their lower limbs. Most of them were from the northern regions of the state. The average time between the appearance of the disease and medical diagnosis was 14 years. The verrucous type proved to be the most frequently reported lesion (53%). Thorn wounds were associated with the disease in 16% of the cases. Lesions uncommon to some parts of the body were also reported. In two of the cases, cutaneous lesions caused by paracoccidioidomycosis and chromoblastomycosis were found in the same patient. Epidermoid carcinoma was found in the same parts of the body affected by chromoblastomycosis. Eumycotic mycetoma and chromoblastomycosis were associated. Fonsecaea pedrosoi was found in 96% of the cases, and Phialophora verrucosa in 4% of the cases.
CONCLUSION: In our study, we observed a predominance of cases in the regions of Missões and Alto Uruguay, followed by the upper and lower northeastern slopes and the lowlands. Severe cases of chromoblastomycosis with intense skin involvement (eg, lesions with carcinoma) were observed. Statistical analysis showed recrudescence of the disease in 43% of cases despite the treatment used.

Entities:  

Mesh:

Year:  2001        PMID: 11260530     DOI: 10.1067/mjd.2001.112220

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  38 in total

1.  Sixty-year-old man with slowly expanding nodular plaque on the thigh.

Authors:  Peggy A Wu; Maria L Turner; Edward W Cowen; Eleanor Wilson; Yvonne R Shea; Timothy Jancel; Alexandra F Freeman
Journal:  J Am Acad Dermatol       Date:  2010-12       Impact factor: 11.527

2.  Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.

Authors:  A Biglino; P Crivelli; E Concialdi; C Bolla; G Montrucchio
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

Review 3.  Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.

Authors:  O Carolina Rojas; Gloria M González; María Moreno-Treviño; Julio Salas-Alanis
Journal:  Mycopathologia       Date:  2014-10-25       Impact factor: 2.574

4.  Subcutaneous fungal infections.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

5.  Melanin in a meristematic mutant of Fonsecaea monophora inhibits the production of nitric oxide and Th1 cytokines of murine macrophages.

Authors:  Junmin Zhang; Li Wang; Liyan Xi; Huaiqiu Huang; Yongxuan Hu; Xiqing Li; Xiao Huang; Sha Lu; Jiufeng Sun
Journal:  Mycopathologia       Date:  2012-10-03       Impact factor: 2.574

Review 6.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease.

Authors:  Solange Corrêa Garcia Pires d'Avila; Carla Pagliari; Maria Irma Seixas Duarte
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

8.  Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+ T cell activation in vitro.

Authors:  M Glória Sousa; E Eid Bou Ghosn; R Ciciro Nascimento; G Facchioli Bomfim; V Noal; K Santiago; C de Maria Pedrozo E Silva Azevedo; S Garcia Marques; A Guedes Gonçalves; D Wagner de Castro Lima Santos; P Ricardo Criado; J Eduardo Costa Martins; S Rogerio Almeida
Journal:  Clin Exp Immunol       Date:  2009-02-04       Impact factor: 4.330

9.  Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.

Authors:  S Deng; W Lei; G S de Hoog; L Yang; R G Vitale; H Rafati; M Seyedmousavi; A Tolooe; H van der Lee; W Liao; P E Verweij; S Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

10.  Right buttock rash for thirty years in a patient from China.

Authors:  Mai Tuyet Pho; Susan Burgin
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.